Back
Bolt Biotherapeutics Stock Price Chart
Sponsored
BOLT
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
42
BOLT
Bolt Biotherapeutics
Last Price:
0.63
Seasonality Move:
-38.25%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BOLT is experiencing selling pressure, which indicates risk of future bearish movement.
Bolt Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.63 | Sell |
20-day SMA: | 0.66 | Sell |
50-day SMA: | 0.7 | Sell |
200-day SMA: | 0.96 | Sell |
8-day EMA: | 0.63 | Sell |
20-day EMA: | 0.65 | Sell |
50-day EMA: | 0.7 | Sell |
200-day EMA: | 0.92 | Sell |
Bolt Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 34.26 | Sell |
Chaikin Money Flow: | -68125 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.63 - 0.69) | Sell |
Bollinger Bands (100): | (0.63 - 0.93) | Sell |
Bolt Biotherapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Bolt Biotherapeutics Stock
Is Bolt Biotherapeutics Stock a Buy?
- Bolt Biotherapeutics share price is 0.62 while BOLT 8-day simple moving average is 0.63, which is a Sell signal.
- The stock price of BOLT is 0.62 while Bolt Biotherapeutics 20-day SMA is 0.66, which makes it a Sell.
- Bolt Biotherapeutics 50-day simple moving average is 0.70 while BOLT share price is 0.62, making it a Sell technically.
- BOLT stock price is 0.62 and Bolt Biotherapeutics 200-day simple moving average is 0.96, creating a Sell signal.
BOLT Technical Analysis vs Fundamental Analysis
Sell
42
Bolt Biotherapeutics (BOLT)
is a Sell
Is Bolt Biotherapeutics a Buy or a Sell?
-
Bolt Biotherapeutics stock is rated a Sell
The current Bolt Biotherapeutics [BOLT] share price is $0.62. The Score for BOLT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Bolt Biotherapeutics Stock Info
Market Cap:
23.8M
Price in USD:
0.62
Share Volume:
75.06K
Bolt Biotherapeutics 52-Week Range
52-Week High:
1.56
52-Week Low:
0.61
Sell
42
Bolt Biotherapeutics (BOLT)
is a Sell
Bolt Biotherapeutics Share Price Forecast
-
What is the Bolt Biotherapeutics stock price today?
The Bolt Biotherapeutics stock price is 0.62 USD today. -
Will BOLT stock go up or go down?
Bolt Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Bolt Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bolt Biotherapeutics is overvalued.
Is Bolt Biotherapeutics Stock a Buy?
- Bolt Biotherapeutics share price is 0.62 while BOLT 8-day exponential moving average is 0.63, which is a Sell signal.
- The stock price of BOLT is 0.62 while Bolt Biotherapeutics 20-day EMA is 0.65, which makes it a Sell.
- Bolt Biotherapeutics 50-day exponential moving average is 0.70 while BOLT share price is 0.62, making it a Sell technically.
- BOLT stock price is 0.62 and Bolt Biotherapeutics 200-day simple moving average is 0.92, creating a Sell signal.
Fundamental Analysis of Bolt Biotherapeutics
Is Bolt Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.59 per share.
Technical Analysis of Bolt Biotherapeutics
Should I short Bolt Biotherapeutics stock?
- BOLT Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Bolt Biotherapeutics is a Sell
- Bolt Biotherapeutics Relative Strength Index (RSI) is 34.26, which suggest Bolt Biotherapeutics is oversold
- The Bollinger Bands (25) for Bolt Biotherapeutics is (0.63 - 0.69), which suggest Bolt Biotherapeutics is a Sell
- The Bollinger Bands (100) for Bolt Biotherapeutics is (0.63 - 0.93), which suggest Bolt Biotherapeutics is a Sell
* Bolt Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.